Variant report

Variant	rs9883222
Chromosome Location	chr3:50267837-50267838
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ELF1	chr3:50267532-50267913	HepG2	liver:	n/a	chr3:50267670-50267683
2	ELF1	chr3:50267363-50267991	GM12878	blood:	n/a	chr3:50267670-50267683
3	MAX	chr3:50267684-50268176	NB4	blood:	n/a	n/a
4	SPI1	chr3:50267623-50268289	GM12878	blood:	n/a	n/a
5	ELF1	chr3:50267533-50267982	MCF-7	breast:	n/a	chr3:50267670-50267683
6	SPI1	chr3:50267512-50268388	HL-60	blood:	n/a	n/a
7	SPI1	chr3:50267758-50268117	GM12891	blood:	n/a	n/a
8	MAX	chr3:50267531-50267845	K562	blood:	n/a	n/a
9	SPI1	chr3:50267754-50268090	GM12878	blood:	n/a	n/a
10	SPI1	chr3:50267678-50268322	HL-60	blood:	n/a	n/a
11	E2F6	chr3:50267584-50267972	K562	blood:	n/a	chr3:50267731-50267742
12	SPI1	chr3:50267777-50268184	GM12891	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:50263607..50266626-chr3:50266942..50271330,6	K562	blood:
2	chr3:50266710..50270196-chr3:50295064..50299749,5	K562	blood:
3	chr3:50266814..50271565-chr3:50304984..50308896,4	MCF-7	breast:
4	chr3:50263738..50266626-chr3:50266942..50270919,4	K562	blood:

Variant related genes	Relation type
GNAI2	TF binding region
ENSG00000230454	Chromatin interaction
ENSG00000114353	Chromatin interaction
ENSG00000012171	Chromatin interaction

Extended variants
information (count: 131 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:103)

rs_ID	r²[population]
rs1005678	0.81[CHB][hapmap]
rs1034408	1.00[CEU][hapmap]
rs1034409	1.00[CEU][hapmap]
rs11130248	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.82[ASN][1000 genomes]
rs11916258	0.85[GIH][hapmap];0.85[TSI][hapmap]
rs12054403	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.82[ASN][1000 genomes]
rs12485390	1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[ASN][1000 genomes]
rs12485909	1.00[CHB][hapmap];1.00[CHD][hapmap];0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs12487392	0.85[ASN][1000 genomes]
rs12488235	0.83[ASN][1000 genomes]
rs12488302	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.85[ASN][1000 genomes]
rs12490809	0.86[JPT][hapmap]
rs12492683	0.82[ASN][1000 genomes]
rs12492880	0.95[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs12493693	0.85[ASN][1000 genomes]
rs12494414	0.95[CHB][hapmap];0.93[CHD][hapmap];0.95[JPT][hapmap];0.82[ASN][1000 genomes]
rs12495261	0.82[ASN][1000 genomes]
rs12497018	0.87[ASN][1000 genomes]
rs12498048	0.96[ASN][1000 genomes]
rs12629572	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs12632110	1.00[CHB][hapmap];0.95[CHD][hapmap];0.82[JPT][hapmap];0.82[ASN][1000 genomes]
rs12721544	0.83[ASN][1000 genomes]
rs1894324	1.00[CEU][hapmap];0.85[GIH][hapmap];0.91[MKK][hapmap];1.00[TSI][hapmap]
rs1989839	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs2006199	0.95[CHB][hapmap];0.93[CHD][hapmap];0.87[JPT][hapmap];0.85[ASN][1000 genomes]
rs2071203	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.87[ASN][1000 genomes]
rs2071204	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs2071205	0.85[ASN][1000 genomes]
rs2071801	0.81[ASN][1000 genomes]
rs2071804	0.90[CHB][hapmap];0.91[JPT][hapmap]
rs2072054	0.81[CHB][hapmap];0.86[CHD][hapmap]
rs2073497	0.82[ASN][1000 genomes]
rs2073499	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs2073500	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.82[ASN][1000 genomes]
rs2229647	0.85[ASN][1000 genomes]
rs2233474	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs2233476	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.81[ASN][1000 genomes]
rs2236940	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.85[LWK][hapmap];0.89[YRI][hapmap];0.81[AFR][1000 genomes];0.94[ASN][1000 genomes]
rs2236941	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.85[LWK][hapmap];0.89[YRI][hapmap];0.81[AFR][1000 genomes];0.95[ASN][1000 genomes]
rs2236943	0.96[ASN][1000 genomes]
rs2236944	1.00[CEU][hapmap];1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap];1.00[TSI][hapmap];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2236946	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.82[ASN][1000 genomes]
rs2236949	0.88[CHB][hapmap];0.88[JPT][hapmap]
rs2269430	1.00[CHB][hapmap];0.87[JPT][hapmap];0.83[ASN][1000 genomes]
rs2269432	1.00[CHB][hapmap];0.95[JPT][hapmap];0.85[ASN][1000 genomes]
rs2269569	0.81[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs2282750	0.94[ASN][1000 genomes]
rs2282751	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs2285043	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs2285044	1.00[CHB][hapmap];0.95[JPT][hapmap];0.85[ASN][1000 genomes]
rs2298953	0.94[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];0.89[LWK][hapmap];1.00[MEX][hapmap];0.97[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.98[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2298954	0.84[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];0.91[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2624839	0.86[CHD][hapmap]
rs3213621	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.86[MEX][hapmap];0.81[ASN][1000 genomes]
rs35455589	1.00[CHB][hapmap];0.95[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.82[ASN][1000 genomes]
rs35587949	1.00[CHB][hapmap];0.98[CHD][hapmap];0.91[JPT][hapmap];0.81[MEX][hapmap];0.82[ASN][1000 genomes]
rs3774739	0.85[CHB][hapmap];0.93[CHD][hapmap]
rs3774752	0.90[CHB][hapmap];0.93[CHD][hapmap]
rs3774753	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];0.95[MEX][hapmap];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs3774754	0.81[ASN][1000 genomes]
rs3774755	1.00[CHB][hapmap];0.95[CHD][hapmap];0.95[JPT][hapmap];0.81[ASN][1000 genomes]
rs4141060	0.83[JPT][hapmap]
rs4141407	1.00[CHB][hapmap];0.95[JPT][hapmap];0.94[ASN][1000 genomes]
rs4688679	1.00[CHB][hapmap];0.95[JPT][hapmap];0.81[ASN][1000 genomes]
rs4688682	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes]
rs4688683	0.87[ASN][1000 genomes]
rs4688724	1.00[CHB][hapmap];0.95[JPT][hapmap];0.81[ASN][1000 genomes]
rs4688725	0.81[ASN][1000 genomes]
rs4688728	0.81[ASN][1000 genomes]
rs4688732	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.82[ASN][1000 genomes]
rs4688733	0.82[ASN][1000 genomes]
rs4688734	1.00[CHB][hapmap];0.97[CHD][hapmap];0.95[JPT][hapmap];0.85[ASN][1000 genomes]
rs4688736	0.83[ASN][1000 genomes]
rs4688738	0.87[ASN][1000 genomes]
rs4688741	1.00[CHB][hapmap];1.00[CHD][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes]
rs4688742	0.96[ASN][1000 genomes]
rs4688744	0.94[ASN][1000 genomes]
rs4688746	0.81[ASN][1000 genomes]
rs57944420	0.81[ASN][1000 genomes]
rs57978992	0.87[ASN][1000 genomes]
rs58181992	0.82[ASN][1000 genomes]
rs58648044	0.81[AFR][1000 genomes];0.94[ASN][1000 genomes]
rs60276643	0.86[ASN][1000 genomes]
rs6446203	1.00[CEU][hapmap];0.85[GIH][hapmap]
rs6767505	1.00[CEU][hapmap]
rs6776145	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs72932959	0.85[ASN][1000 genomes]
rs72932987	0.82[ASN][1000 genomes]
rs743754	1.00[CEU][hapmap]
rs743755	1.00[CEU][hapmap]
rs7626470	1.00[CEU][hapmap]
rs7634307	1.00[CEU][hapmap]
rs7636862	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap];0.83[YRI][hapmap]
rs7641224	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs7645537	1.00[CHB][hapmap];1.00[CHD][hapmap];0.95[JPT][hapmap];0.86[MEX][hapmap];0.96[ASN][1000 genomes]
rs7647409	1.00[CEU][hapmap]
rs886075	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs9311449	0.80[ASN][1000 genomes]
rs9828829	1.00[CEU][hapmap]
rs9830408	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[YRI][hapmap];0.97[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs9852677	0.86[CHB][hapmap];0.93[CHD][hapmap];0.91[JPT][hapmap];0.95[MEX][hapmap];0.89[AMR][1000 genomes];0.82[ASN][1000 genomes]
rs9875873	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs9882618	0.83[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
3	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
4	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
5	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
6	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
7	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
8	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
9	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
10	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
11	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
12	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
13	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
14	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
15	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
16	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
17	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
19	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
20	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
21	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
22	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
25	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
26	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
27	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
28	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:86 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50265600-50268000	Weak transcription	Brain Anterior Caudate	brain
2	chr3:50265600-50269200	Enhancers	Primary B cells from cord blood	blood
3	chr3:50265600-50269200	Enhancers	Primary B cells from peripheral blood	blood
4	chr3:50265600-50272400	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr3:50265600-50273000	Weak transcription	Right Atrium	heart
6	chr3:50265800-50268000	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr3:50265800-50268000	Weak transcription	Brain Substantia Nigra	brain
8	chr3:50265800-50268200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr3:50265800-50268200	Enhancers	Esophagus	oesophagus
10	chr3:50265800-50268200	Enhancers	GM12878-XiMat	blood
11	chr3:50265800-50268200	Weak transcription	HSMM	muscle
12	chr3:50265800-50268200	Weak transcription	Osteobl	bone
13	chr3:50265800-50268400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr3:50265800-50268400	Enhancers	Duodenum Mucosa	Duodenum
15	chr3:50265800-50268400	Enhancers	Placenta	Placenta
16	chr3:50265800-50268600	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr3:50265800-50268600	Enhancers	HepG2	liver
18	chr3:50265800-50268800	Enhancers	Primary hematopoietic stem cells	blood
19	chr3:50265800-50269000	Enhancers	Adipose Nuclei	Adipose
20	chr3:50265800-50270200	Weak transcription	Fetal Heart	heart
21	chr3:50265800-50270400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
22	chr3:50265800-50270600	Weak transcription	Cortex derived primary cultured neurospheres	brain
23	chr3:50265800-50271600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr3:50265800-50272400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr3:50265800-50273000	Weak transcription	H9 Cell Line	embryonic stem cell
26	chr3:50266000-50268400	Weak transcription	Stomach Smooth Muscle	stomach
27	chr3:50266000-50272800	Weak transcription	Colonic Mucosa	Colon
28	chr3:50266200-50268000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr3:50266200-50270000	Weak transcription	Fetal Intestine Small	intestine
30	chr3:50266200-50271800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
31	chr3:50266200-50272000	Weak transcription	Fetal Muscle Leg	muscle
32	chr3:50266200-50272600	Weak transcription	Fetal Intestine Large	intestine
33	chr3:50266200-50273000	Weak transcription	Fetal Stomach	stomach
34	chr3:50266400-50268000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr3:50266400-50268000	Weak transcription	NHDF-Ad	bronchial
36	chr3:50266400-50270200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
37	chr3:50266400-50272000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr3:50266400-50272400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr3:50266400-50272400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr3:50266400-50272600	Weak transcription	Thymus	Thymus
41	chr3:50266400-50272800	Weak transcription	Fetal Lung	lung
42	chr3:50266400-50273000	Weak transcription	Fetal Brain Female	brain
43	chr3:50266400-50273200	Weak transcription	NHLF	lung
44	chr3:50266400-50273400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr3:50266600-50268000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
46	chr3:50266600-50268200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr3:50266600-50270400	Weak transcription	H1 Cell Line	embryonic stem cell
48	chr3:50266600-50270800	Weak transcription	HUES64 Cell Line	embryonic stem cell
49	chr3:50266600-50270800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
50	chr3:50266600-50270800	Weak transcription	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links